Equine Healthcare Market (2025 - 2033)

Equine Healthcare Market Summary

The global equine healthcare market size was estimated at USD 3.22 billion in 2024 and is projected to reach USD 6.41 billion by 2033, growing at a CAGR of 8.20% from 2025 to 2033. The market growth is primarily owing to a high equine population worldwide, advancements in veterinary technology and medicine, increasing sports activities, and awareness of nutrition and preventive healthcare.

For instance, according to the survey data published by the American Horse Council in 2024, over 6.6 million horses were recorded in the U.S. in 2023. Thus, a high population is expected to spur the demand for effective equine healthcare, thereby accelerating market growth potential in the country. Growing demand for advanced equine healthcare systems, especially in geographies where people participate in sports and leisure activities such as recreational riding, polo, show jumping, and horse racing. These equestrian activities enhance the economic value of horses, allowing owners to invest in healthcare solutions and conveniently accessible services. Moreover, there is an expansion of demand in vaccines, biologics, pharmaceuticals, supplements, and rehabilitation services. As equine sports gain popularity globally, the demand for healthcare providers, product manufacturers, and the sale of medicine is augmented, keeping the growth curve high.

Increasing awareness among pet owners regarding the importance of preventive healthcare is another main factor influencing the market. Owners and trainers extensively use routine veterinary examinations, immunizations, and dietary supplements to preserve longevity and performance. Horses' general health can be improved, and treatment costs can be reduced by taking preventive measures like dental care, parasite control, and early disease identification. In addition, specialized nutritional solutions that promote vitality, immunity, and joint health are growing in popularity. Veterinarian consultations, educational programs, and advancements in equine diagnostic technologies impact this trend. As a result, preventive healthcare is essential to business growth.

Ongoing developments in veterinary medicine and diagnostic technologies drive the horse healthcare sector. Innovations, including regenerative medicines, portable imaging devices, molecular diagnostics, and advanced surgical techniques, are improving equine ailments' diagnosis, management, and treatment as they offer individualized treatment for conditions like lameness, respiratory issues, and genetic abnormalities, precision medicine methods, and genomic testing. Furthermore, a study aimed to give thorough information on identifying significant diagnostic and prognostic markers in horses with EMPF was published in the Journal of Veterinary Medicine in April 2024. The researchers established key diagnostic criteria, including fever, fast breathing, weight loss, and breathing difficulties. The study also found that more research is required to identify prognostic markers to improve treatment outcomes. Telemedicine and wearable monitoring devices also enhance real-time health tracking and remote consultations. Long-term market growth is fueled by these developments, which enhance health results and increase owners' and trainers' confidence in contemporary veterinary treatment.

Key Technological Advancements Driving the Equine Healthcare Market

Source: Journal of Equine Veterinary Science, Veterinary Clinics of North America: Equine Practice.

Market Concentration & Characteristics

The equine healthcare industry exhibits a moderate concentration, and the pace of growth is accelerating. Global players such as Zoetis, Arthrex Inc., and Boehringer Ingelheim International GmbH hold significant revenue shares in the market. These companies leverage strong R&D, broad portfolios, and global distribution networks to maintain competitiveness.

Horse healthcare is particularly inventive, with advancements in diagnostic imaging, regenerative medicine, and wearable monitoring technology contributing to better care outcomes. Precision nutrition, genetic testing, and nutraceuticals are becoming more popular since they allow for better performance and early illness prevention. In June 2024, Sleip, a renowned software provider of equine health monitoring and analysis tools, partnered with Boehringer Ingelheim (BI). BI chose to employ Sleip's AI-enhanced equine gait analysis tool for musculoskeletal issues to increase awareness of the importance of preventive and diagnostic care for horses.

The equine healthcare industry is witnessing a surge in M&A activity as major animal health companies and specialty veterinarian groups look to expand their geographic reach and portfolios through acquisitions. In April 2025, Creative Science, a CIMA Animal Health firm, acquired Astaria Global. By adding science-based equine health products to its portfolio, the acquisition expands its market reach and encourages innovation. Such initiatives boost market competitiveness, fortify supply chains, and encourage innovation in fields such as vaccines, biologics, and specialty equine care.

Regulations governing veterinarian practices, feed safety, and drug approvals are crucial in equine medicine. Strict laws governing medications, nutritional products, and biologics ensure safety and efficacy, but they also increase the cost of compliance. Government agencies and local veterinary associations set horse welfare, trade, and treatment rules. These procedures influence market acceptance rates and mold product development plans.

Product substitutions impact the market for horse healthcare; some owners frequently favor natural feeding, herbal medicines, and conventional therapy. Although conventional veterinary drugs are still required, the increasing need for all-encompassing care drives the creation of hybrid treatments that blend pharmaceutical and natural components. This trend encourages companies to be innovative and offer integrated solutions that balance efficacy, safety, and owner preferences.

Regional market development is one of the most important growth strategies in the equine healthcare sector. Global firms are concentrating on expanding their markets in Latin America, Asia-Pacific, and the Middle East. Several companies are implementing expansion strategies to reach new markets and stimulate revenue streams by expanding distribution networks, establishing strategic partnerships with regional veterinary associations, and implementing localized production.

Activity Insights

The sports and racing segment accounted for the largest revenue share in 2024. The segment demand is owing to the high economic value and severe care needed for performance horses. Horses used in show jumping, polo, racing, and other competitive sports require specific veterinary care, such as immunizations, nutritional supplements, and injury treatment. Increase in need for horse healthcare goods and services due to frequent training, travel, and competition, and vulnerability to musculoskeletal injuries, infections, and metabolic diseases. Further, owners and trainers make large investments in diagnostics, treatments, and monitoring systems to preserve top performance, extend careers, and guarantee horses' general health and well-being, accelerating market demand in the near future.

Recreation is expected to witness the fastest growth rate over the analysis timeframe. The increasing popularity of leisure riding, trail riding, and equestrian tourism drives the segmental demand. Recreational horses, though not used in high-intensity sports, still require routine veterinary care, vaccinations, deworming, and preventive health management to maintain well-being. Moreover, rising disposable incomes and awareness of animal welfare led owners to invest in advanced healthcare products, supplements, and diagnostic services for their horses. In addition, the growth of riding schools, equestrian clubs, and therapeutic riding programs has expanded the market for preventive and routine equine healthcare solutions in the recreation segment.

Product Insights

The pharmaceuticals segment held the largest revenue share of 26.09% in 2024, driven by high demand for preventive, therapeutic, and specialty medications for horses. Increasing incidence of equine diseases, rising awareness among horse owners, and the growing adoption of veterinary-prescribed medications contribute to robust market growth. Products include anti-infectives, anti-inflammatories, analgesics, and vaccines that improve animal health and performance. Leading pharmaceutical companies focus on research and development, innovative drug formulations, and strategic partnerships to expand their equine healthcare portfolios. Continuous advancements in biologics, regenerative therapies, and targeted treatments further boost segmental revenue growth in the market.

The software and services segment in the market is expanding at the highest rate, owing to the growing usage of digital solutions for managing equine health. Advanced veterinary software, telemedicine systems, and data analytics technologies offer real-time monitoring, disease tracking, and predictive care, enhancing overall animal welfare and operational effectiveness. Moreover, IoT device integration, growing demand for cloud-based solutions to improve treatment and performance, and growing awareness of precision equestrian care are anticipated to propel the segmental growth potential at a higher pace in the forthcoming years.

Indication Insights

Parasitic infections account for the largest revenue share in 2024, owing to the strong presence of internal and external parasites in horses. There is a constant need for efficient parasiticides since parasites like strongyles, tapeworms, and ticks can cause serious health problems such as colic, anaemia, and weight loss. Long-acting medications, combination therapy, and advanced formulations are used more frequently to improve convenience and efficacy.

On the other hand, the Equine Herpes Virus (EHV) segment is anticipated to grow at the fastest rate over the forecast period. This high growth can be attributed to the increasing prevalence of EHV among various types of horses and recent reports of EHV outbreaks. For instance, as per an April 2024 study from Science Direct, the prevalence of EHV was reported to be high in lactating horses (81.6%) and pregnant horses (74.6%) compared to other types of horses. In addition, in February 2024, another Science Direct research study published in September 2023 reported an outbreak of EHV during an equestrian event, the CES Valencia Spring Tour 2021, causing fever in over 83.3% of the participant horses. These instances highlight the need for proper diagnostic and therapeutic care of horses against the increasing risk of EHV, driving the segment over the forecast period.

Distribution Channel Insights

Veterinary hospitals and clinics accounted for the largest revenue share in 2024. The segment demand is attributable to rising demand for specialized equine medical services. These facilities cater to healthcare services for sport, racing, and recreational horses with complete care, including diagnostics, surgical procedures, preventive treatments, and emergency services. Moreover, growing investment in innovative veterinary facilities and technology and increased awareness among horse owners about animal welfare are expected to drive segmental growth.

The e-commerce segment is anticipated to grow fastest over the forecast period. The high segmental growth potential stems from increased preference for online platforms among horse owners and equine professionals for faster care and ease of use. Digital platforms provide easy access to a variety of goods at affordable costs, such as medications, dietary supplements, medical equipment, and diagnostics. Moreover, smartphone apps, online veterinary consultations, and doorstep delivery services are accelerating segment growth. E-commerce lessens dependency on traditional retail by enabling quick product availability in urban and rural areas.

Regional Insights

North America equine healthcare market held the largest revenue share of 32.88% in 2024, due to welfare spending, equestrian activities, and advancements in diagnostics and regenerative therapies. Moreover, continuously evolving regulatory frameworks in the region to ensure health and welfare among horses are expected to drive regional growth. For instance, in May 2024, the U.S. Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) enhanced the Horse Protection Regulations to inhibit intentional horse soring. Horse owners do this activity by inflicting intentional pain on the horse to gain an advantage in sports/racing activities, but it can be detrimental to the horse’s health.

U.S. Equine Healthcare Market Trends

The equine healthcare market in the U.S. is growing due to the growth of equestrian activities and the standardization of treatment protocols for horses. For instance, in March 2024, the American Association of Equine Practitioners (AAEP) released vaccination protocols for five crucial equine diseases affecting horses in the U.S.: West Nile virus, tetanus, equine encephalomyelitis, and rabies.

Europe Equine Healthcare Market Trends

The equine healthcare market in Europe is driven by the elevated prevalence of equine diseases, the expansion of equestrian activities, the adoption of innovative technologies in the management of equine healthcare, and the growing number of horses on the continent. The number of horses in Europe is increasing, and as a result, likewise is the amount spent on equine-related activities. According to data from January 2024 provided by PetKeen, there are an estimated 1 million horses in the UK, and the country spends about GBP 4 billion (USD 5.1 billion) a year on equestrian-related activities.

The UK equine healthcare market is witnessing significant growth in Europe, driven by strong veterinary infrastructure, growing equestrian sports, and rising welfare standards. The wide array of approved therapies is growing due to advancements in surgical methods, diagnostics, and preventative care. For instance, in August 2025, the Royal Veterinary College approved uniportal endoscopic foraminotomy for cervical spinal nerve compression, which is a major achievement that provides afflicted horses with minimally invasive treatment.

The equine healthcare market in Germany has the second-largest share of the European market. The growing popularity of horse racing and other equestrian activities is one of the main factors driving this market. As a result, the demand for horse healthcare goods and veterinary services has increased. Furthermore, the government's emphasis on animal welfare and the strict laws pertaining to horses' health and safety further support this sector's expansion.

Asia Pacific Equine Healthcare Market Trends

The equine healthcare market in Asia Pacific is anticipated to witness the fastest growth rate over the estimated timeline. The regional growth is driven by rising horse ownership, expanding equestrian sports, and increasing awareness of equine welfare. For instance, increasing regional countries' emphasis on improving horse welfare by different means, such as improving regulatory standards, conducting education & training programs, among others. For instance, in July 2024, the Chinese Equestrian Association, with assistance from the FEI. conducted education and training programs for horse stable managers across China. This was done to raise the standards of care for horses by developing trained individuals.

India equine healthcare market is expected to grow at a substantial rate over the forecast period. This can be attributed to the growing variety of applications of horses in the country and the subsequent need for proper healthcare protocols. For instance, the Directorate of Health Services in Kashmir, in July 2024, started a novel initiative, a horse ambulance, to provide healthcare support to the pilgrims attending the Amarnath Yatra pilgrimage. Considering the immense attendance in such pilgrimages, a proper healthcare regime is also crucial in ensuring that these horses remain in good health. Therefore, such activities act as boosting factors to the country’s market.

Latin America Equine Healthcare Market Trends

The equine healthcare market in Latin America is driven by the growing prevalence of encephalitis among the region's equine population. According to February 2024 data by the WHO, over 1419 Western Equine Encephalitis (WEE) outbreaks have been reported in countries like Argentina. This drives up the demand for diagnostic and treatment products in the regions to avert future outbreaks. Moreover, strong equestrian traditions, growing horse ownership, and the need for innovative veterinary treatment are driving the growth of the equine healthcare industry in Latin America.

Brazil equine healthcare market is expected to rise due to the increasing popularity of horse racing in the country. Brazil's robust equestrian culture, growing breeding programs, and rising investments in horse welfare are key factors driving the country's equine healthcare industry. Improvements in immunizations, infectious disease diagnostics, and regenerative therapies also strengthen equine care. In addition, government support and the evolving veterinary infrastructure propel the country’s position as the largest market in the region.

Middle East & Africa Equine Healthcare Market Trends

The equine healthcare market in the MEA is majorly driven by growing focus on horse health due to increasing penetration of equestrian sports. The countries from the region are actively involved in promoting equestrian sports. For instance, as per April 2024 reports by FEI, Saudi Arabian officials, in collaboration with FEI, conducted FEI World Cup Finals in the city of Riyadh. Such activities bring in the demand for equine products in the countries from the region, boosting the market revenue growth.

South Africa equine healthcare market is expanding due to a growing racing and breeding industry, increased veterinary awareness, and rising horse welfare costs. Moreover, the increasing presence of key players includes Zoetis, Boehringer Ingelheim, and Merck Animal Health. Modern wellness technologies and advancements in innovative therapies, imaging, and immunizations are strengthening the South African market.

Key Equine Healthcare Company Insights

Key players operating in the market include Zoetis Services LLC, Dechra, Boehringer Ingelheim, and Arthex.Inc. These players implement numerous growth strategies such as product launches, expansion, mergers, acquisitions, and partnerships to gain significant market share. Furthermore, companies are concentrating on developing goods that cater to particular demands in the equine healthcare sector. By combining these programs, companies cater to the changing needs of horse owners and veterinarians and enhance the equine healthcare industry.

Recent Developments

• In June 2025, bioMérieux introduced VETFIRE, a ready-to-use PCR kit for equine infectious respiratory diseases. It provides accurate results in under 20 minutes and simultaneous detection of seven pathogens with advanced, high-sensitivity PCR technology.

• In April 2025, Creative Science, a CIMA Animal Health company, acquired Astaria Global. This acquisition enhanced equine health offerings with innovative orthobiologic therapies for pain management and inflammatory airway disease, expanded veterinary solutions, and improved horse wellness.

• In August 2024, Hyloris Pharmaceuticals developed HY-095, a long-acting injectable proton pump inhibitor for Equine Gastric Ulcer Syndrome. The drug aims to improve delivery, reduce dosing frequency, and address unmet veterinary medical needs.

Equine Healthcare Market